Citi analyst, Garen Sarafian, reiterated his Buy rating on shares of athenahealth (NASDAQ: ATHN) and raised his price target to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE